These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23674175)

  • 1. Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability.
    Tran Mau-Them F; Willems M; Albrecht B; Sanchez E; Puechberty J; Endele S; Schneider A; Ruiz Pallares N; Missirian C; Rivier F; Girard M; Holder M; Manouvrier S; Touitou I; Lefort G; Sarda P; Moncla A; Drunat S; Wieczorek D; Genevieve D
    Eur J Hum Genet; 2014 Feb; 22(2):289-92. PubMed ID: 23674175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic exome sequencing identifies two novel IQSEC2 mutations associated with X-linked intellectual disability with seizures: implications for genetic counseling and clinical diagnosis.
    Gandomi SK; Farwell Gonzalez KD; Parra M; Shahmirzadi L; Mancuso J; Pichurin P; Temme R; Dugan S; Zeng W; Tang S
    J Genet Couns; 2014 Jun; 23(3):289-98. PubMed ID: 24306141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IQSEC2 in syndromic intellectual disability: Narrowing the diagnostic odyssey.
    Helm BM; Powis Z; Prada CE; Casasbuenas-Alarcon OL; Balmakund T; Schaefer GB; Kahler SG; Kaylor J; Winter S; Zarate YA; Schrier Vergano SA
    Am J Med Genet A; 2017 Oct; 173(10):2814-2820. PubMed ID: 28815955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlation: Inheritance and variant-type infer pathogenicity in IQSEC2 gene.
    Barrie ES; Cottrell CE; Gastier-Foster J; Hickey SE; Patel AD; Santoro SL; Alfaro MP
    Eur J Med Genet; 2020 Mar; 63(3):103735. PubMed ID: 31415821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
    Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
    Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQSEC2 mutation update and review of the female-specific phenotype spectrum including intellectual disability and epilepsy.
    Shoubridge C; Harvey RJ; Dudding-Byth T
    Hum Mutat; 2019 Jan; 40(1):5-24. PubMed ID: 30328660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal mosaicism of a novel IQSEC2 variant causing female limited intellectual disability and epilepsy.
    Ewans LJ; Field M; Zhu Y; Turner G; Leffler M; Dinger ME; Cowley MJ; Buckley MF; Scheffer IE; Jackson MR; Roscioli T; Shoubridge C
    Eur J Hum Genet; 2017 Jun; 25(6):763-767. PubMed ID: 28295038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdeletion of the escape genes KDM5C and IQSEC2 in a girl with severe intellectual disability and autistic features.
    Fieremans N; Van Esch H; de Ravel T; Van Driessche J; Belet S; Bauters M; Froyen G
    Eur J Med Genet; 2015 May; 58(5):324-7. PubMed ID: 25858702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IQSEC2 and X-linked syndromal intellectual disability.
    Alexander-Bloch AF; McDougle CJ; Ullman Z; Sweetser DA
    Psychiatr Genet; 2016 Jun; 26(3):101-8. PubMed ID: 27010919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.
    Redin C; Gérard B; Lauer J; Herenger Y; Muller J; Quartier A; Masurel-Paulet A; Willems M; Lesca G; El-Chehadeh S; Le Gras S; Vicaire S; Philipps M; Dumas M; Geoffroy V; Feger C; Haumesser N; Alembik Y; Barth M; Bonneau D; Colin E; Dollfus H; Doray B; Delrue MA; Drouin-Garraud V; Flori E; Fradin M; Francannet C; Goldenberg A; Lumbroso S; Mathieu-Dramard M; Martin-Coignard D; Lacombe D; Morin G; Polge A; Sukno S; Thauvin-Robinet C; Thevenon J; Doco-Fenzy M; Genevieve D; Sarda P; Edery P; Isidor B; Jost B; Olivier-Faivre L; Mandel JL; Piton A
    J Med Genet; 2014 Nov; 51(11):724-36. PubMed ID: 25167861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.
    Allou L; Julia S; Amsallem D; El Chehadeh S; Lambert L; Thevenon J; Duffourd Y; Saunier A; Bouquet P; Pere S; Moustaïne A; Ruaud L; Roth V; Jonveaux P; Philippe C
    Clin Genet; 2017 Mar; 91(3):431-440. PubMed ID: 27062609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.
    Olson HE; Tambunan D; LaCoursiere C; Goldenberg M; Pinsky R; Martin E; Ho E; Khwaja O; Kaufmann WE; Poduri A
    Am J Med Genet A; 2015 Sep; 167A(9):2017-25. PubMed ID: 25914188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of intellectual disability reveals a novel mutation in IQSEC2 gene by whole exome sequencing.
    Zou Q; Zheng J; Zhang R; Fang Y; Cai C
    Psychiatr Genet; 2019 Dec; 29(6):243-247. PubMed ID: 31490346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?
    Lopergolo D; Privitera F; Castello G; Lo Rizzo C; Mencarelli MA; Pinto AM; Ariani F; Currò A; Lamacchia V; Canitano R; Vaghi E; Ferrarini A; Baltodano GM; Lederer D; Van Maldergem L; Serrano M; Pineda M; Fons-Estupina MDC; Van Esch H; Breckpot J; Kumps C; Callewaert B; Mueller S; Ramelli GP; Armstrong J; Renieri A; Mari F
    Clin Genet; 2021 Mar; 99(3):462-474. PubMed ID: 33368194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.
    Madrigal I; Alvarez-Mora MI; Rosell J; Rodríguez-Revenga L; Karlberg O; Sauer S; Syvänen AC; Mila M
    Eur J Hum Genet; 2016 Aug; 24(8):1117-23. PubMed ID: 26733290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.
    Cobben JM; Weiss MM; van Dijk FS; De Reuver R; de Kruiff C; Pondaag W; Hennekam RC; Yntema HG
    Eur J Med Genet; 2014; 57(11-12):636-8. PubMed ID: 25281490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next-Generation Sequencing in Patients with Suggestive X-Linked Intellectual Disability.
    Ibarluzea N; Hoz AB; Villate O; Llano I; Ocio I; Martí I; Guitart M; Gabau E; Andrade F; Gener B; Tejada MI
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31906484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous loss of function of
    Jackson MR; Loring KE; Homan CC; Thai MH; Määttänen L; Arvio M; Jarvela I; Shaw M; Gardner A; Gecz J; Shoubridge C
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31439632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability.
    Muthusamy B; Selvan LDN; Nguyen TT; Manoj J; Stawiski EW; Jaiswal BS; Wang W; Raja R; Ramprasad VL; Gupta R; Murugan S; Kadandale JS; Prasad TSK; Reddy K; Peterson A; Pandey A; Seshagiri S; Girimaji SC; Gowda H
    OMICS; 2017 May; 21(5):295-303. PubMed ID: 28481730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.